Sign In
Pharma
Lupin gets USFDA nod for generic product, Sildenafil
Industry
Lupin receives tentative USFDA nod for Azilsartan Medoxomil tablets
Lupin launches diagnostics biz
Lupin, TB Alliance join hands for new therapy for drug-resistant Tuberculosis
USFDA issues warning letter on Lupin's Somerset facility, cites repeated violations at company's manufacturing facilities
Markets
Lupin introduces digital educator platform for asthma patients
Lupin change gears to bring Covid-19 drugs in market; approaches Gilead for Remdesivir
Lupin share dips 2% after delayed-release of Posaconazole tablets
Lupin reports Rs 438.3 crore net profit in Q3 FY21
Economy
Lupin launches generic immunosuppressant drug in US
